医学
以兹提米比
他汀类
内科学
动脉粥样硬化性心血管疾病
强度(物理)
心脏病学
疾病
荟萃分析
物理疗法
物理
量子力学
作者
Francinny Alves Kelly,Francisco Cézar Aquino de Moraes,Artur de Oliveira Macena Lôbo,Victória Morbach Siebel,Marianna Leite,Artur Menegaz de Almeida,Fernanda Marciano Consolim‐Colombo
标识
DOI:10.1016/j.jacl.2024.07.013
摘要
Atherosclerotic cardiovascular disease (ASCVD), affects approximately 18.6 million individuals worldwide and poses a significant healthcare related challenge. Despite the established efficacy of both high-intensity statin monotherapy (HIS) and moderate-intensity statin plus ezetimibe (MIS+EZT) in ASCVD management, the optimal treatment strategy remains unclear.
科研通智能强力驱动
Strongly Powered by AbleSci AI